• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Brochures

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Sterile Fill-Finish facility: Your integrated partner for customized clinical supplies

Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for clinical supply of sterile drug products having short development timelines.

ADME/PK profiling capabilities

Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.

Chemistry process research lab for Drug Discovery

Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.

SynVantage AI-enhanced relay-based drug discovery for optimizing Design-Make-Test-Analyze (DMTA) cycle

SynVantage is Syngene’s platform that enables a continuous and seamless transition between different stages of a DMTA cycle thereby reducing timelines for early drug discovery.

Building resilience in Supply Chain Management - the Syngene way

Syngene has a well-defined system that delivers across all aspects of Supply Chain Management, ranging from planning and inventory to sourcing, procurement, logistics, performance, safety, and compliance.

Comprehensive solutions for clinical development of generic drugs

Synene has developed more than 100 assays for conducting BA/BE studies across small and large molecules.

ICH Stability Services

One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC 

Targeted Protein Degradation_PROTACs

Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.

Syngene Biologics Development & Manufacturing
Syngene Chemical Development

Syngene  has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details